...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: NBD?

Now that makes some sense, I probably wasn't alone in wondering about Pfizer filing a patent application for Apabetalone, now with your post things are much clearer. 

As for SanFran's musings about Resverlogix holding the proverbial trump card....I dunno about that.  

In once corner we have Pfizer, a company with a Market Cap of close to $200 Billion US dollars with billions of cash on its balance sheet.  And in the opposing corner we have Resverlogix.  "ResverWhat"???  Resverlogix, a tiny Canadian firm based in Calgary weighing in with a Market Cap of a little over $200 million, uhm... that's $200 million Canadian....with a balance sheet that has, uhm....well, they have a balance sheet.  

Now these two are negotiating....if you're Pfizer are you going to pay big bucks to a company that seems to be basically broke? Or are you gonna be like Homer Simpson buying Ned Flanders' Bible for 7 cents.  

https://youtu.be/FSZ40xu4QTA

 

 

 

 

Share
New Message
Please login to post a reply